Skip to main content
Terug
Watch Compare

VSEE HEALTH, INC.

Datakwaliteit: 100%
Ook genoteerd als VSEEW NASDAQ
VSEE
NASDAQ Services Health Services
€ 0,23
▼ € 0,01 (-2,09%)
6 months return
—
Momentum
Neutral
Net margin
-100,65%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)40,27%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-100,65%
Op. Margin-65,55%

Veiligheid

Debt / Equity
N/A
Current Ratio0,16
Interest Coverage-3,41

Waardering

PE (TTM)
-0,78
Boven sectorgemiddelde (-1,19)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -3,48 M
Capital efficient — spends only 0,20% of revenue on capex

Price History

Financiële Trends

Koersdoel Analisten

Geen analistendekking beschikbaar

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) 40,27% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: -100,65%
Revenue (TTM) 14,62 M Net Income (TTM) -14,71 M
ROE N/A ROA -79,71%
Gross Margin 50,32% Operating Margin -65,55%
Net Margin -100,65% Free Cash Flow (TTM) -3,48 M
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0,16
Debt / Equity N/A Current Ratio 0,16
Interest Coverage -3,41 Asset Turnover 0,79
Working Capital -19,70 M Tangible Book Value -19,83 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,78 · EV/EBITDA: N/A
P/E Ratio -0,78 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,78
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -30,31%
Market Cap 11,47 M Enterprise Value 14,43 M

Per Share

EPS: -0,73 · FCF/Share: -0,07
EPS (Diluted TTM) -0,73 Revenue / Share 0,31
FCF / Share -0,07 OCF / Share -0,07
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 23,62% · CapEx/Rev: 0,20%
CapEx / Revenue 0,20% FCF Conversion 23,62%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 14,62 M 10,42 M — —
Net Income -14,71 M -57,70 M -4,41 M -3,24 M
EPS (Diluted) -0,73 -5,65 -1,08 -0,25
Gross Profit 7,36 M 7,18 M — —
Operating Income -9,58 M -62,15 M -2,59 M -3,59 M
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A 2,59 M 1,32 M — —
Interest Expense 2,81 M 211.459,0 — 125.980,0
Income Tax 68.426,0 -1,64 M 187.225,0 187.225,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 22,41 M 19,99 M 1,37 M 7,63 M
Total Liabilities 16,96 M 20,01 M 12,35 M 7,67 M
Shareholders' Equity 5,45 M -18.488,0 -12,27 M -7,43 M
Total Debt 2,74 M 1,93 M — —
Cash & Equivalents 5,27 M 326.115,0 1.863,0 106.998,0
Current Assets 8,37 M 3,02 M 1.863,0 106.998,0
Current Liabilities 16,24 M 19,01 M 7,98 M 3,30 M

Sectorvergelijking

vs Services sector mediaan (615 peers)
Metriek Aandeel Sector Mediaan
P/E -0,8 -1,2
P/B — 1,4
ROE % — -16,2
Net Margin % -100,7 -19,4
Rev Growth 5Y % — 4,0
D/E — 0,4